Építés alatt – nem éles oldal
Belépés
Fut, nem toborozFázis nélkül

BGP+ Stent as Bridging Stent in BEVAR

A legfontosabb adatok

Ki végzi
Marc Bosiers, MD
Hol
Németország10 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Fut, nem toboroz
Résztvevők
118 fő, tervezett
Kezdés
2020. szept. 9.
Befejezés
2025. júl. 31.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • BGP+ Stent Graft System as bridging stent
A regiszteradat frissítve
2025. április 9.

Ki vehet részt

Életkor
55 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 34 feltétel megnézéseKevesebb

Ki vehet részt

  • Patient eligible for elective repair of TAAA with BEVAR in accordance with the applicable guidelines for vascular interventions (e.g. Aneurysm size 6cm or aneurysm growth of >5mm within 6 months or 1cm within 1 year)
  • Patient is willing to comply with specified follow-up evaluations at the specified times
  • Patient is >55 years old
  • Patient understands the nature of the procedure and provides written informed consent, prior to enrolment in the trial; Patient has a projected life-expectancy of at least 12-months
  • Patient needs to have a landing zone in their target vessel of at least 15 mm, and coverage/ wall adaptation of the BGP+ should be obtained for at least 10 mm
  • The access vessel for introduction of the sheath through which the BGP+ will be advanced should be at least 3mm (it should be able to fit a 8F sheath)
  • No early important division branch from the target vessel with risk of coverage
  • Absence of pre-existing dissection in the target vessels
  • Target vessels (renal arteries, superior mesenteric artery, and celiac trunk) for the BGP+ must have a diameter between 5 and 10 mm
  • Aortic endoprosthesis with inner branches (can be hybrid or branches only)
  • Hybrid aortic endoprosthesis with fenestrations and branches (at least 2 and only the target vessels which are connected by a branch shall be treated with a study device within this study)
  • At least one target vessel is bridged with only one BGP+ (relining allowed)
  • Full compliance with all inclusion criteria/exclusion criteria and all intraoperative criteria

Ki nem vehet részt

  • Previously implanted stent in the target vessel
  • Patients for whom antiplatelet therapy, anticoagulants or thrombolytic drugs are contraindicated
  • Any planned surgical intervention/procedure within 30 days of the trial procedure
  • Patient is currently participating in another conflicting investigational drug or device trial that has not completed the entire follow up period
  • Hybrid Approach (endovascular in combination with open surgery)
  • Myocardial infarction or stroke within 3 months prior to the procedure
  • Patients with uncorrected bleeding disorders or heparin induced thrombocytopenia
  • Patients with diffuse distal disease resulting in poor stent outflow
  • Patients with known hypersensitivity to the stent material (L605) and/or PTFE
  • Patients with a connective tissue disorder
  • Patients with an unstable angina pectoris or heart insufficiency NYHA 3 or 4
  • Patients with access vessel which are too tortuous, narrow or any kind of reason that would lead to failure of introducing and advancing an introducer sheath
  • Renal artery with >100° cranial orientation
  • Patients refusing treatment
  • Female patient with childbearing potential not taking adequate contraceptives or currently breastfeeding
  • Patients with rupture or any patient considered to be hemodynamically unstable at onset of procedure
  • Fresh thrombus formation within the last 14 days
  • Patients with mycotic or inflammatory aneurysm
  • Patients with ASA classification 5 or higher
  • Contraindications against contrast enhanced angiography (a.e. massive hyperthyroidism)
  • Patients with increased risk of intraoperative rupture

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

The objective of this clinical investigation is to evaluate, in a controlled setting, the safety and performance of the BGP+ balloon expandable covered stent Graft System (Bentley InnoMed, Hechingen, Germany) implanted as bridging stent in BEVAR (branched endovascular aortic repair) for complex aortic aneurysms.

A vizsgálat csoportja

  • BGP+ Stent Graft SystemA vizsgált kezelés

    Application of BeGraft Peripheral Plus (BGP+) Stent Graft System as bridging stent in Branched Endovascular Repair (BEVAR) for complex aortic aneurysms

    Kezelés: BGP+ Stent Graft System as bridging stent

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Physician-Initiated Trial Investigating the BeGraft Peripheral Plus Stent Graft System as Bridging Stent in BEVAR for Complex Aortic Aneurysms
A regiszteradat frissítve
2025. április 9.